Alter, B.P., Kupfer, G., Fanconi anemia. Pagon, R.A., Adam, M.P., Ardinger, H.H., Wallace, S.E., Amemiya, A., Bean, L.J., Bird, T.D., Fong, C.-T., Mefford, H.C., Smith, R.J., Stephens, K., (eds.) GeneReviews(®), 1993, University of Washington, Seattle, Seattle (WA).
Amunugama, R., Groden, J., Fishel, R., The HsRAD51B-HsRAD51C stabilizes the HsRAD51 nucleoprotein filament. DNA Repair 12 (2013), 723–732, 10.1016/j.dnarep.2013.05.005.
Auerbach, A.D., Diagnosis of Fanconi anemia by diepoxybutane analysis. Curr. Protoc. Hum. Genet. Board Jonathan Haines Al, vol. 85, 2015, 10.1002/0471142905.hg0807s85 8.7.1–17.
Auerbach, A.D., Fanconi anemia and its diagnosis. Mutat. Res. 668 (2009), 4–10, 10.1016/j.mrfmmm.2009.01.013.
Auerbach, A.D., Diagnosis of fanconi anemia by diepoxybutane analysis. Curr. Protoc. Hum. Genet. Board Jonathan Haines Al Chapter 8, 2003, 10.1002/0471142905.hg0807s37 Unit 8.7.
Buratti, E., Chivers, M., Královicová J., Romano, M., Baralle, M., Krainer, A.R., Vorechovsky, I., Aberrant 5’ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization. Nucleic Acids Res. 35 (2007), 4250–4263, 10.1093/nar/gkm402.
Cheung, R.S., Taniguchi, T., Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers. Int. J. Hematol., 2017, 1–10, 10.1007/s12185-017-2283-4.
Duxin, J.P., Walter, J.C., What is the DNA repair defect underlying Fanconi anemia?. Curr. Opin. Cell Biol. 37 (2015), 49–60, 10.1016/j.ceb.2015.09.002.
Giampietro, P.F., Adler-Brecher, B., Verlander, P.C., Pavlakis, S.G., Davis, J.G., Auerbach, A.D., The need for more accurate and timely diagnosis in Fanconi anemia: a report from the International Fanconi Anemia Registry. Pediatrics 91 (1993), 1116–1120.
Khincha, P.P., Savage, S.A., Neonatal manifestations of inherited bone marrow failure syndromes. Semin. Fetal Neonatal Med. 21 (2016), 57–65, 10.1016/j.siny.2015.12.003.
Kuznetsov, S.G., Haines, D.C., Martin, B.K., Sharan, S.K., Loss of Rad51c leads to embryonic lethality and modulation of Trp53-dependent tumorigenesis in mice. Canc. Res. 69 (2009), 863–872, 10.1158/0008-5472.CAN-08-3057.
Kuznetsov, S., Pellegrini, M., Shuda, K., Fernandez-Capetillo, O., Liu, Y., Martin, B.K., Burkett, S., Southon, E., Pati, D., Tessarollo, L., West, S.C., Donovan, P.J., Nussenzweig, A., Sharan, S.K., RAD51C deficiency in mice results in early prophase I arrest in males and sister chromatid separation at metaphase II in females. J. Cell Biol. 176 (2007), 581–592, 10.1083/jcb.200608130.
Liu, P., Yuan, B., Carvalho, C.M.B., Wuster, A., Walter, K., Zhang, L., Gambin, T., Chong, Z., Campbell, I.M., Coban Akdemir, Z., Gelowani, V., Writzl, K., Bacino, C.A., Lindsay, S.J., Withers, M., Gonzaga-Jauregui, C., Wiszniewska, J., Scull, J., Stankiewicz, P., Jhangiani, S.N., Muzny, D.M., Zhang, F., Chen, K., Gibbs, R.A., Rautenstrauss, B., Cheung, S.W., Smith, J., Breman, A., Shaw, C.A., Patel, A., Hurles, M.E., Lupski, J.R., An organismal CNV mutator phenotype restricted to early human development. Cell, 168, 2017, e7, 10.1016/j.cell.2017.01.037 830–842.
Miller, K.A., Sawicka, D., Barsky, D., Albala, J.S., Domain mapping of the Rad51 paralog protein complexes. Nucleic Acids Res. 32 (2004), 169–178, 10.1093/nar/gkg925.
Pang, Z., Yao, L., Zhang, J., Ouyang, T., Li, J., Wang, T., Fan, Z., Fan, T., Lin, B., Xie, Y., RAD51C germline mutations in Chinese women with familial breast cancer. Breast Canc. Res. Treat. 129 (2011), 1019–1020, 10.1007/s10549-011-1574-3.
Pavlakis, S.G., Frissora, C.L., Giampietro, P.F., Davis, J.G., Gould, R.J., Adler-Brecher, B., Auerbach, A.D., Fanconi anemia: a model for genetic causes of abnormal brain development. Dev. Med. Child Neurol. 34 (1992), 1081–1084.
Somyajit, K., Subramanya, S., Nagaraju, G., Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility. J. Biol. Chem. 287 (2012), 3366–3380, 10.1074/jbc.M111.311241.
Sopik, V., Akbari, M.r., Narod, S. a, Genetic testing for RAD51C mutations: in the clinic and community. Clin. Genet. 88 (2015), 303–312, 10.1111/cge.12548.
Stivaros, S.M., Alston, R., Wright, N.B., Chandler, K., Bonney, D., Wynn, R.F., Will, A.M., Punekar, M., Loughran, S., Kilday, J.-P., Schindler, D., Patel, L., Meyer, S., Central nervous system abnormalities in Fanconi anaemia: patterns and frequency on magnetic resonance imaging. Br. J. Radiol., 88, 2015, 20150088, 10.1259/bjr.20150088.
Vaz, F., Hanenberg, H., Schuster, B., Barker, K., Wiek, C., Erven, V., Neveling, K., Endt, D., Kesterton, I., Autore, F., Fraternali, F., Freund, M., Hartmann, L., Grimwade, D., Roberts, R.G., Schaal, H., Mohammed, S., Rahman, N., Schindler, D., Mathew, C.G., Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat. Genet. 42 (2010), 406–409, 10.1038/ng.570.
Vetro, A., Iascone, M., Limongelli, I., Ameziane, N., Gana, S., Della Mina, E., Giussani, U., Ciccone, R., Forlino, A., Pezzoli, L., Rooimans, M.A., van Essen, A.J., Messa, J., Rizzuti, T., Bianchi, P., Dorsman, J., de Winter, J.P., Lalatta, F., Zuffardi, O., Loss-of-Function FANCL mutations associate with severe fanconi anemia overlapping the VACTERL association. Hum. Mutat. 36 (2015), 562–568, 10.1002/humu.22784.
Wapner, R.J., Martin, C.L., Levy, B., Ballif, B.C., Eng, C.M., Zachary, J.M., Savage, M., Platt, L.D., Saltzman, D., Grobman, W.A., Klugman, S., Scholl, T., Simpson, J.L., McCall, K., Aggarwal, V.S., Bunke, B., Nahum, O., Patel, A., Lamb, A.N., Thom, E.A., Beaudet, A.L., Ledbetter, D.H., Shaffer, L.G., Jackson, L., Chromosomal microarray versus karyotyping for prenatal diagnosis. N. Engl. J. Med. 367 (2012), 2175–2184, 10.1056/NEJMoa1203382.